These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38808433)

  • 1. [Applications and challenges of pathomics technique in the management of hepatocellular carcinoma].
    Chen ZX; Chen JM; Geng XP; Liu FB
    Zhonghua Wai Ke Za Zhi; 2024 Jul; 62(7):665-670. PubMed ID: 38808433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence in the diagnosis and management of hepatocellular carcinoma.
    Sato M; Tateishi R; Yatomi Y; Koike K
    J Gastroenterol Hepatol; 2021 Mar; 36(3):551-560. PubMed ID: 33709610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma.
    Bo Z; Song J; He Q; Chen B; Chen Z; Xie X; Shu D; Chen K; Wang Y; Chen G
    Comput Biol Med; 2024 May; 173():108337. PubMed ID: 38547656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.
    Wei J; Jiang H; Zhou Y; Tian J; Furtado FS; Catalano OA
    Dig Liver Dis; 2023 Jul; 55(7):833-847. PubMed ID: 36641292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Omics and Artificial Intelligence-Guided Data Integration in Chronic Liver Disease: Prospects and Challenges for Precision Medicine.
    Lin B; Ma Y; Wu S
    OMICS; 2022 Aug; 26(8):415-421. PubMed ID: 35925812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of radiomics with artificial intelligence in precise diagnosis and treatment of hepatocellular carcinoma].
    Li YH; Jia WD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):905-909. PubMed ID: 33256273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.
    Aquino IMC; Pascut D
    Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma.
    Liang Q; Shen X; Sun G
    Curr Med Chem; 2018; 25(17):1999-2008. PubMed ID: 29345573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of proteomics in different aspects of hepatocellular carcinoma research.
    Xing X; Liang D; Huang Y; Zeng Y; Han X; Liu X; Liu J
    J Proteomics; 2016 Aug; 145():70-80. PubMed ID: 27072111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics in Hepatocellular Carcinoma.
    Sagir Kahraman A
    J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives in pathomics in head and neck cancer.
    Classe M; Lerousseau M; Scoazec JY; Deutsch E
    Curr Opin Oncol; 2021 May; 33(3):175-183. PubMed ID: 33782358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research of artificial intelligence-based clinical decision support system for primary hepatocellular carcinoma].
    Yang J; Guo F; Lyu T; Yan LN; Wen TF; Yang JY; Wu H; Wang WT; Song JL; Xu H; Zhang QH
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(48):3870-3873. PubMed ID: 33371633
    [No Abstract]   [Full Text] [Related]  

  • 13. New challenges in clinical research on hepatocellular carcinoma.
    Díaz-González Á; Forner A; Rodríguez de Lope C; Varela M
    Rev Esp Enferm Dig; 2016 Aug; 108(8):485-93. PubMed ID: 26653993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?
    Hesketh RL; Zhu AX; Oklu R
    Am J Clin Oncol; 2015 Aug; 38(4):431-6. PubMed ID: 25238287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection.
    Xie Q; Zhao Z; Yang Y; Wang X; Wu W; Jiang H; Hao W; Peng R; Luo C
    Cancer Med; 2024 Jun; 13(11):e7374. PubMed ID: 38864473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence: A review of current applications in hepatocellular carcinoma imaging.
    Pellat A; Barat M; Coriat R; Soyer P; Dohan A
    Diagn Interv Imaging; 2023 Jan; 104(1):24-36. PubMed ID: 36272931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting.
    Burak KW; Sherman M
    Can J Gastroenterol Hepatol; 2015 May; 29(4):178-84. PubMed ID: 25965437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of Clinical Research on Hepatocellular Carcinoma.
    Kudo M; Kitano M; Sakurai T; Nishida N
    Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence and Precision Medicine: Outcome of Immunotherapy in Hepatocellular Carcinoma.
    Theodros E; Nagaraju GP
    Crit Rev Immunol; 2022; 42(6):1-8. PubMed ID: 37082946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in basic and clinical research on hepatocellular carcinoma in 2016].
    Dong ZZ; Zhu XD; Li Z; Mao YG; Chai YL; Yao DF; Sun HC; Zhu JY; Ma KS
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):85-93. PubMed ID: 28297792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.